Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial (Q33330612)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial
scientific article

    Statements

    Gemcitabine as second-line treatment for advanced non-small-cell lung cancer: A phase II trial (English)
    2081-2085

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit